In 2023, China's pharmaceutical equipment industry will develop towards the goal of "automation, intelligence and digitalization"

2. Total profit of China's pharmaceutical equipment industry

In 2022, China's pharmaceutical equipment sales revenue was 29.869 billion yuan, and the total profit was 3.563 billion yuan, with a nominal growth rate of 0.28%.

6. Competition pattern of pharmaceutical equipment industry

1. Competition pattern of pharmaceutical equipment industry

The pattern of the domestic pharmaceutical equipment industry is scattered, and the industry concentration has a large room for improvement, with a CR4 of 34% in 2020. According to data, Dongfulong and Chutian Technology accounted for 13.7% and 10.2% of the domestic market in 2020, which is located in the first echelon of the domestic industry. It was followed by Xinhua Medical and Canaan Technology, accounting for 5.4% and 5.1% of the market, respectively, and the remaining 65.66% of the market share was occupied by other enterprises.

2. Revenue of key enterprises in pharmaceutical equipment industry

Dongfulong is a comprehensive pharmaceutical equipment service provider that provides global pharmaceutical enterprises with pharmaceutical process, core equipment and overall system engineering solutions. After nearly 30 years of hard work, more than 10,000 pharmaceutical equipment and drug manufacturing systems have served more than 2,000 world-renowned pharmaceutical companies in more than 40 countries and regions around the world. Through more than 20 years of development, Chutian Technology has developed into one of the leading enterprises in the domestic pharmaceutical equipment industry, and has also become one of the well-known enterprises in the global pharmaceutical equipment industry.

Vii. Future development trend of pharmaceutical equipment industry

With the gradual implementation of various pharmaceutical reforms and other measures, the pharmaceutical equipment industry will continue to accelerate innovation and upgrading, technology from imitation innovation to the direction of independent innovation and research and development, more and more independent research and development products are gradually replacing imports, toward the goal of "automation, intelligence, digital" development. The leading domestic pharmaceutical equipment enterprises, which have accumulated technological and R&D advantages in the early development, will expand their own service areas through internal and external extension and upstream and downstream integration, improve the quality and performance of equipment, so as to continuously improve the market share, gradually transform to the overall solution supplier, and constantly improve the overall turnkey engineering capability. Promote the construction of future pharmaceutical industry 4.0 pharmaceutical system.